Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹21,219.8
₹45,091 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,997.6
₹35,841 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,181.9
₹15,143 Cr
Pharmaceuticals & Drugs
₹538.1
₹10,577 Cr
Pharmaceuticals & Drugs
₹410.6
₹3,802 Cr
Pharmaceuticals & Drugs
₹273.3
₹3,056 Cr
Pharmaceuticals & Drugs
₹68.8
₹1,765 Cr
Pharmaceuticals & Drugs
₹540.0
₹308 Cr
Pharmaceuticals & Drugs
₹24.6
₹188 Cr
Pharmaceuticals & Drugs
₹63.8
₹134 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,997.6
₹10,759 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹538.1
₹5,425 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,181.9
₹3,597 Cr
Pharmaceuticals & Drugs
₹410.6
₹2,668 Cr
Pharmaceuticals & Drugs
₹273.3
₹525 Cr
Pharmaceuticals & Drugs
₹24.6
₹188 Cr
Pharmaceuticals & Drugs
₹68.8
₹97 Cr
Pharmaceuticals & Drugs
₹63.8
₹90 Cr
Pharmaceuticals & Drugs
₹540.0
₹332 Cr
Pharmaceuticals & Drugs
₹21,219.8
₹5,163 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,997.6
₹1,121 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹1,181.9
₹674 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹538.1
₹283 Cr
Pharmaceuticals & Drugs
₹410.6
₹166 Cr
Pharmaceuticals & Drugs
₹273.3
₹98 Cr
Pharmaceuticals & Drugs
₹68.8
₹74 Cr
Pharmaceuticals & Drugs
₹24.6
₹16 Cr
Pharmaceuticals & Drugs
₹63.8
₹5 Cr
Pharmaceuticals & Drugs
₹540.0
₹34 Cr
Pharmaceuticals & Drugs
₹21,219.8
₹882 Cr

STOCK ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

You may also like the below Video Courses